Assembly Biosciences, Inc.
HEPATITIS B CORE PROTEIN MODULATORS

Last updated:

Abstract:

The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compound of formula: ##STR00001##

Status:
Application
Type:

Utility

Filling date:

14 Jan 2021

Issue date:

27 Jan 2022